Stockreport

TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance

TriSalus Life Sciences, Inc.  (TLSI) 
PDF Fourth quarter 2025 revenue of approximately $13.2 million, Up 60% Year-Over-YearFull-year 2025 revenue growth of approximately 53% exceeded 2025 guidanceSet initial 202 [Read more]